Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT
1 other identifier
interventional
36
1 country
1
Brief Summary
The current study is a prospective randomised study Evaluation of 2%Bromelain Gel With 0.2%Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing in Stage II/III and Grade B Periodontitis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 11, 2024
CompletedFirst Posted
Study publicly available on registry
July 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedJanuary 13, 2025
January 1, 2025
1 year
July 11, 2024
January 9, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Probing pocket Depth (PPD)
measured using a UNC-15 probe (university of North Carolina-15 periodontal probe- Hu-Friedy, Chicago, IL, USA
3 months
Relative attachment level (RAL)
(university of North Carolina-15 periodontal probe- Hu-Friedy, Chicago, IL, USA)
3 months
Secondary Outcomes (3)
Plaque Index
3 months
Gingival index
3 month
Modified Sulcus Bleeding Index
3 months
Study Arms (3)
GROUP 1-SRP alone
ACTIVE COMPARATORcontrol group is treated with SRP alone
GROUP 2-0.2% BROMELAIN gel
EXPERIMENTALtest group is treated with bromelain gel
GROUP 3-0.2% CHLORHEXIDINE gel
ACTIVE COMPARATORtest group is treated with chlorhexidine gel
Interventions
bromelain gel is prepared from bromelain capsules in laboratory
Eligibility Criteria
You may qualify if:
- Patient with have chronic periodontitis in the age group between 30-50 years.
- Patients having ≥20 teeth.
- Patients with radiographic evidence of bone loss in atleast two teeth.
- Patients who are systematically healthy.
- Patients with localized pockets with probing depth of ≤ 5mm.
- Patients who are cooperative and able to attend the hospital for regular follow-up.
You may not qualify if:
- Patients who have received any surgical or nonsurgical therapy during past 6months
- Pregnant or lactating females.
- Use of systemic antibiotics in the past 6 months.
- Patient who are not willing to give a written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. NALLAGATLA VAMSI VENKATA KRISHNA SAI
Bengaluru, Karnataka, 562157, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 11, 2024
First Posted
July 17, 2024
Study Start
July 1, 2024
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
January 13, 2025
Record last verified: 2025-01